SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6gng'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR)	6gng	- (-)	5 / 12	LEU A 373 LEU A 377 GLY A 378 ALA A 406 LEU A 398	None	1.13A	1gs4A-6gngA: undetectable	1gs4A-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MRL_B_DOLB301_1 (STREPTOGRAMIN A ACETYLTRANSFERASE)	6gng	- (-)	5 / 12	ILE A 291 ASN A 200 LEU A 256 ASN A 301 VAL A 41	None QPS A 601 (-4.2A) None QPS A 601 (-3.2A) None	1.49A	1mrlB-6gngA: undetectable 1mrlC-6gngA: undetectable	1mrlB-6gngA: undetectable 1mrlC-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_I_BEZI517_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	6gng	- (-)	4 / 7	ILE A 495 PRO A 430 PHE A 353 ALA A 363	None	1.12A	1oniG-6gngA: undetectable 1oniI-6gngA: undetectable	1oniG-6gngA: undetectable 1oniI-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RBP_A_RTLA183_0 (PLASMA RETINOL-BINDING PROTEIN PRECURSOR)	6gng	- (-)	5 / 12	LEU A 137 ALA A 142 ALA A 145 ALA A 141 VAL A 80	None	1.36A	1rbpA-6gngA: undetectable	1rbpA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SN0_C_T44C601_1 (TRANSTHYRETIN)	6gng	- (-)	5 / 9	LEU A 420 ALA A 422 LEU A 336 MET A 429 ALA A 352	None	1.42A	1sn0A-6gngA: undetectable 1sn0C-6gngA: undetectable	1sn0A-6gngA: undetectable 1sn0C-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_A_NCTA1208_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	6gng	- (-)	4 / 8	TYR A 532 TRP A 525 CYH A 436 LEU A 441	None None QPS A 601 (-4.8A) None	1.44A	1uw6A-6gngA: undetectable 1uw6B-6gngA: undetectable	1uw6A-6gngA: undetectable 1uw6B-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_D_NCTD1208_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	6gng	- (-)	4 / 8	TYR A 532 TRP A 525 CYH A 436 LEU A 441	None None QPS A 601 (-4.8A) None	1.40A	1uw6D-6gngA: undetectable 1uw6E-6gngA: undetectable	1uw6D-6gngA: undetectable 1uw6E-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_G_NCTG1206_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	6gng	- (-)	4 / 8	TYR A 532 TRP A 525 CYH A 436 LEU A 441	None None QPS A 601 (-4.8A) None	1.40A	1uw6G-6gngA: undetectable 1uw6H-6gngA: undetectable	1uw6G-6gngA: undetectable 1uw6H-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_P_NCTP1206_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	6gng	- (-)	4 / 8	TYR A 532 TRP A 525 CYH A 436 LEU A 441	None None QPS A 601 (-4.8A) None	1.46A	1uw6P-6gngA: undetectable 1uw6Q-6gngA: undetectable	1uw6P-6gngA: undetectable 1uw6Q-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UW6_T_NCTT1208_1 (ACETYLCHOLINE-BINDIN G PROTEIN)	6gng	- (-)	4 / 8	LEU A 441 TYR A 532 TRP A 525 CYH A 436	None None None QPS A 601 (-4.8A)	1.44A	1uw6P-6gngA: undetectable 1uw6T-6gngA: undetectable	1uw6P-6gngA: undetectable 1uw6T-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ECP_A_ACRA992_1 (MALTODEXTRIN PHOSPHORYLASE)	6gng	- (-)	5 / 10	LEU A 38 TYR A 120 ASP A 127 ASP A 169 ARG A 356	QPS A 601 (-4.1A) QPS A 601 (-4.4A) QPS A 601 (-2.9A) QPS A 601 (-3.3A) ADP A 602 ( 3.6A)	0.99A	2ecpA-6gngA: 22.5	2ecpA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ECP_A_ACRA992_1 (MALTODEXTRIN PHOSPHORYLASE)	6gng	- (-)	5 / 10	LEU A 38 TYR A 120 ASP A 169 HIS A 171 ARG A 356	QPS A 601 (-4.1A) QPS A 601 (-4.4A) QPS A 601 (-3.3A) QPS A 601 (-4.2A) ADP A 602 ( 3.6A)	0.88A	2ecpA-6gngA: 22.5	2ecpA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ECP_B_ACRB992_1 (MALTODEXTRIN PHOSPHORYLASE)	6gng	- (-)	5 / 10	LEU A 38 TYR A 120 ASP A 127 ASP A 169 ARG A 356	QPS A 601 (-4.1A) QPS A 601 (-4.4A) QPS A 601 (-2.9A) QPS A 601 (-3.3A) ADP A 602 ( 3.6A)	0.94A	2ecpB-6gngA: 22.5	2ecpB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ECP_B_ACRB992_1 (MALTODEXTRIN PHOSPHORYLASE)	6gng	- (-)	5 / 10	LEU A 38 TYR A 120 ASP A 169 HIS A 171 ARG A 356	QPS A 601 (-4.1A) QPS A 601 (-4.4A) QPS A 601 (-3.3A) QPS A 601 (-4.2A) ADP A 602 ( 3.6A)	0.87A	2ecpB-6gngA: 22.5	2ecpB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G78_A_REAA200_1 (CELLULAR RETINOIC ACID-BINDING PROTEIN 2)	6gng	- (-)	5 / 12	ALA A 141 THR A 72 VAL A 87 LEU A 151 MET A 57	None	1.13A	2g78A-6gngA: undetectable	2g78A-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_A_SAMA500_0 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	6gng	- (-)	5 / 12	GLY A 121 GLY A 125 THR A 115 SER A 27 PHE A 135	None QPS A 601 (-3.4A) None None None	1.06A	2okcA-6gngA: undetectable	2okcA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YLD_A_ASCA130_0 (CYTOCHROME C')	6gng	- (-)	4 / 5	ALA A 369 GLY A 498 CYH A 499 LYS A 500	None	1.25A	2yldA-6gngA: undetectable	2yldA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YLG_A_ASCA130_0 (CYTOCHROME C')	6gng	- (-)	4 / 5	ALA A 369 GLY A 498 CYH A 499 LYS A 500	None	1.43A	2ylgA-6gngA: undetectable	2ylgA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D91_A_REMA350_2 (RENIN)	6gng	- (-)	4 / 5	TYR A 384 ALA A 406 ALA A 424 TYR A 426	None	1.29A	3d91A-6gngA: undetectable	3d91A-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_B_EPAB1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	6gng	- (-)	5 / 12	PHE A 470 GLY A 498 ILE A 494 GLY A 362 ALA A 363	None	0.98A	3hs6B-6gngA: undetectable	3hs6B-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_E_URFE254_1 (URIDINE PHOSPHORYLASE)	6gng	- (-)	4 / 6	GLY A 284 GLN A 204 ILE A 291 VAL A 277	None	1.10A	3kvvE-6gngA: undetectable	3kvvE-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q5S_A_ACHA1289_0 (MULTIDRUG-EFFLUX TRANSPORTER 1 REGULATOR)	6gng	- (-)	4 / 6	ASN A 216 TYR A 183 GLU A 144 ILE A 78	None	1.16A	3q5sA-6gngA: undetectable	3q5sA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZWI_A_ASCA156_0 (CYTOCHROME C')	6gng	- (-)	4 / 5	ALA A 369 GLY A 498 CYH A 499 LYS A 500	None	1.28A	3zwiA-6gngA: undetectable	3zwiA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1478_0 (TRANSLATION ELONGATION FACTOR SELB)	6gng	- (-)	4 / 7	GLY A 298 ILE A 299 THR A 539 PHE A 536	None	0.87A	4acaC-6gngA: 6.1	4acaC-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1V_B_URFB1301_1 (URIDINE PHOSPHORYLASE)	6gng	- (-)	4 / 7	GLY A 284 GLN A 204 ILE A 291 VAL A 277	None	1.07A	4e1vB-6gngA: undetectable	4e1vB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1V_F_URFF1301_1 (URIDINE PHOSPHORYLASE)	6gng	- (-)	4 / 6	GLY A 284 GLN A 204 ILE A 291 VAL A 277	None	1.11A	4e1vF-6gngA: undetectable	4e1vF-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5O_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	6gng	- (-)	4 / 7	ILE A 483 GLN A 242 PRO A 243 ILE A 245	None	1.07A	4w5oA-6gngA: 2.2	4w5oA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4E_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	6gng	- (-)	4 / 7	ILE A 483 GLN A 242 PRO A 243 ILE A 245	None	1.08A	4z4eA-6gngA: 4.2	4z4eA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA902_0 (PROTEIN ARGONAUTE-2)	6gng	- (-)	4 / 7	ILE A 483 GLN A 242 PRO A 243 ILE A 245	None	1.07A	4z4gA-6gngA: 2.5	4z4gA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_O_BEZO801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	6gng	- (-)	4 / 6	SER A 27 HIS A 171 MET A 138 LEU A 119	None QPS A 601 (-4.2A) None None	1.10A	5dzka-6gngA: undetectable 5dzko-6gngA: undetectable	5dzka-6gngA: undetectable 5dzko-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_P_BEZP801_1 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	6gng	- (-)	4 / 6	SER A 27 HIS A 171 MET A 138 LEU A 119	None QPS A 601 (-4.2A) None None	1.27A	5dzkB-6gngA: 3.2 5dzkP-6gngA: undetectable	5dzkB-6gngA: undetectable 5dzkP-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESG_A_1YNA701_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	6gng	- (-)	5 / 12	GLU A 434 VAL A 452 GLY A 408 THR A 410 LEU A 357	QPS A 601 ( 3.7A) None None None None	1.10A	5esgA-6gngA: undetectable	5esgA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JLI_A_ASCA202_0 (CYTOCHROME C')	6gng	- (-)	4 / 5	ALA A 369 GLY A 498 CYH A 499 LYS A 500	None	1.36A	5jliA-6gngA: undetectable	5jliA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JT4_A_ASCA202_0 (CYTOCHROME C')	6gng	- (-)	4 / 5	ALA A 369 GLY A 498 CYH A 499 LYS A 500	None	1.33A	5jt4A-6gngA: undetectable	5jt4A-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JW1_B_CELB602_2 (PROSTAGLANDIN G/H SYNTHASE 2)	6gng	- (-)	4 / 6	VAL A 529 VAL A 166 ARG A 99 ILE A 59	None	1.08A	5jw1B-6gngA: 0.0	5jw1B-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	6gng	- (-)	5 / 12	GLY A 355 PHE A 353 VAL A 462 GLY A 457 PRO A 450	ADP A 602 ( 4.1A) None None None None	1.04A	5tuiB-6gngA: undetectable	5tuiB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VNC_C_GCSC801_1 (GLYCOGEN [STARCH] SYNTHASE ISOFORM 2)	6gng	- (-)	5 / 10	ARG A 356 ASN A 301 LYS A 361 GLU A 434 GLY A 437	ADP A 602 ( 3.6A) QPS A 601 (-3.2A) ADP A 602 (-2.8A) QPS A 601 ( 3.7A) ADP A 602 ( 3.6A)	1.36A	5vncC-6gngA: 21.8	5vncC-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VNC_C_GCSC801_1 (GLYCOGEN [STARCH] SYNTHASE ISOFORM 2)	6gng	- (-)	8 / 10	GLY A 37 HIS A 199 VAL A 269 ASN A 301 LYS A 361 GLU A 434 PRO A 435 GLY A 437	ADP A 602 ( 3.4A) QPS A 601 (-4.4A) QPS A 601 ( 4.7A) QPS A 601 (-3.2A) ADP A 602 (-2.8A) QPS A 601 ( 3.7A) QPS A 601 (-3.9A) ADP A 602 ( 3.6A)	0.72A	5vncC-6gngA: 21.8	5vncC-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIQ_D_HFGD1002_1 (PROLYL-TRNA SYNTHETASE (PRORS))	6gng	- (-)	3 / 3	THR A 35 GLU A 28 HIS A 171	QPS A 601 ( 3.0A) QPS A 601 ( 4.1A) QPS A 601 (-4.2A)	0.91A	5xiqD-6gngA: 3.4	5xiqD-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_A_ACRA602_1 (-)	6gng	- (-)	11 / 12	GLY A 36 GLY A 37 VAL A 41 ASP A 169 VAL A 269 ASN A 301 ARG A 356 GLN A 360 PRO A 435 CYH A 436 GLY A 437	ADP A 602 ( 3.5A) ADP A 602 ( 3.4A) None QPS A 601 (-3.3A) QPS A 601 ( 4.7A) QPS A 601 (-3.2A) ADP A 602 ( 3.6A) QPS A 601 (-3.2A) QPS A 601 (-3.9A) QPS A 601 (-4.8A) ADP A 602 ( 3.6A)	0.48A	6gneA-6gngA: 42.2	6gneA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_A_ACRA602_2 (-)	6gng	- (-)	6 / 6	TYR A 120 TRP A 170 HIS A 199 ASN A 200 TYR A 203 GLU A 434	QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-3.9A) QPS A 601 ( 3.7A)	0.57A	6gneA-6gngA: 42.2	6gneA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_B_ACRB602_1 (-)	6gng	- (-)	11 / 12	GLU A 28 GLY A 36 GLY A 37 VAL A 41 ASP A 169 VAL A 269 ASN A 301 ARG A 356 GLN A 360 PRO A 435 GLY A 437	QPS A 601 ( 4.1A) ADP A 602 ( 3.5A) ADP A 602 ( 3.4A) None QPS A 601 (-3.3A) QPS A 601 ( 4.7A) QPS A 601 (-3.2A) ADP A 602 ( 3.6A) QPS A 601 (-3.2A) QPS A 601 (-3.9A) ADP A 602 ( 3.6A)	0.49A	6gneB-6gngA: 41.9	6gneB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_B_ACRB602_2 (-)	6gng	- (-)	7 / 8	TYR A 120 TRP A 170 HIS A 199 ASN A 200 TYR A 203 GLU A 434 CYH A 436	QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-3.9A) QPS A 601 ( 3.7A) QPS A 601 (-4.8A)	0.60A	6gneB-6gngA: 41.9	6gneB-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_A_QPSA602_1 (-)	6gng	- (-)	11 / 12	VAL A 41 ASP A 127 ASP A 169 HIS A 171 ASN A 200 ASN A 301 ARG A 356 GLN A 360 GLU A 434 PRO A 435 GLY A 437	None QPS A 601 (-2.9A) QPS A 601 (-3.3A) QPS A 601 (-4.2A) QPS A 601 (-4.2A) QPS A 601 (-3.2A) ADP A 602 ( 3.6A) QPS A 601 (-3.2A) QPS A 601 ( 3.7A) QPS A 601 (-3.9A) ADP A 602 ( 3.6A)	0.39A	6gnfA-6gngA: 54.4	6gnfA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_A_QPSA602_2 (-)	6gng	- (-)	8 / 9	THR A 35 GLY A 36 GLY A 37 TYR A 120 TRP A 170 HIS A 199 VAL A 269 CYH A 436	QPS A 601 ( 3.0A) ADP A 602 ( 3.5A) ADP A 602 ( 3.4A) QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-4.4A) QPS A 601 ( 4.7A) QPS A 601 (-4.8A)	0.28A	6gnfA-6gngA: 54.4	6gnfA-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_C_QPSC602_1 (-)	6gng	- (-)	8 / 10	THR A 35 GLY A 37 LEU A 38 TYR A 120 TRP A 170 HIS A 199 VAL A 269 CYH A 436	QPS A 601 ( 3.0A) ADP A 602 ( 3.4A) QPS A 601 (-4.1A) QPS A 601 (-4.4A) QPS A 601 (-4.2A) QPS A 601 (-4.4A) QPS A 601 ( 4.7A) QPS A 601 (-4.8A)	0.33A	6gnfC-6gngA: 52.3	6gnfC-6gngA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNF_C_QPSC602_2 (-)	6gng	- (-)	11 / 12	VAL A 41 ASP A 127 ASP A 169 HIS A 171 ASN A 200 ASN A 301 ARG A 356 GLN A 360 GLU A 434 PRO A 435 GLY A 437	None QPS A 601 (-2.9A) QPS A 601 (-3.3A) QPS A 601 (-4.2A) QPS A 601 (-4.2A) QPS A 601 (-3.2A) ADP A 602 ( 3.6A) QPS A 601 (-3.2A) QPS A 601 ( 3.7A) QPS A 601 (-3.9A) ADP A 602 ( 3.6A)	0.41A	6gnfC-6gngA: 52.3	6gnfC-6gngA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GS4_A_ZK5A1918_1","ANDROGEN RECEPTOR","6gng","-","-",5,"LEU A 373;LEU A 377;GLY A 378;ALA A 406;LEU A 398","None","1.13A","1gs4A-6gngA:undetectable","1gs4A-6gngA:undetectable"],["1MRL_B_DOLB301_1","STREPTOGRAMIN A ACETYLTRANSFERASE;STREPTOGRAMIN A ACETYLTRANSFERASE","6gng","-","-",5,"ILE A 291;ASN A 200;LEU A 256;ASN A 301;VAL A  41","None;QPS A 601 (-4.2A);None;QPS A 601 (-3.2A);None","1.49A","1mrlB-6gngA:undetectable;1mrlC-6gngA:undetectable","1mrlB-6gngA:undetectable;1mrlC-6gngA:undetectable"],["1ONI_I_BEZI517_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","6gng","-","-",4,"ILE A 495;PRO A 430;PHE A 353;ALA A 363","None","1.12A","1oniG-6gngA:undetectable;1oniI-6gngA:undetectable","1oniG-6gngA:undetectable;1oniI-6gngA:undetectable"],["1RBP_A_RTLA183_0","PLASMA RETINOL-BINDING PROTEIN PRECURSOR","6gng","-","-",5,"LEU A 137;ALA A 142;ALA A 145;ALA A 141;VAL A  80","None","1.36A","1rbpA-6gngA:undetectable","1rbpA-6gngA:undetectable"],["1SN0_C_T44C601_1","TRANSTHYRETIN;TRANSTHYRETIN","6gng","-","-",5,"LEU A 420;ALA A 422;LEU A 336;MET A 429;ALA A 352","None","1.42A","1sn0A-6gngA:undetectable;1sn0C-6gngA:undetectable","1sn0A-6gngA:undetectable;1sn0C-6gngA:undetectable"],["1UW6_A_NCTA1208_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","6gng","-","-",4,"TYR A 532;TRP A 525;CYH A 436;LEU A 441","None;None;QPS A 601 (-4.8A);None","1.44A","1uw6A-6gngA:undetectable;1uw6B-6gngA:undetectable","1uw6A-6gngA:undetectable;1uw6B-6gngA:undetectable"],["1UW6_D_NCTD1208_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","6gng","-","-",4,"TYR A 532;TRP A 525;CYH A 436;LEU A 441","None;None;QPS A 601 (-4.8A);None","1.40A","1uw6D-6gngA:undetectable;1uw6E-6gngA:undetectable","1uw6D-6gngA:undetectable;1uw6E-6gngA:undetectable"],["1UW6_G_NCTG1206_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","6gng","-","-",4,"TYR A 532;TRP A 525;CYH A 436;LEU A 441","None;None;QPS A 601 (-4.8A);None","1.40A","1uw6G-6gngA:undetectable;1uw6H-6gngA:undetectable","1uw6G-6gngA:undetectable;1uw6H-6gngA:undetectable"],["1UW6_P_NCTP1206_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","6gng","-","-",4,"TYR A 532;TRP A 525;CYH A 436;LEU A 441","None;None;QPS A 601 (-4.8A);None","1.46A","1uw6P-6gngA:undetectable;1uw6Q-6gngA:undetectable","1uw6P-6gngA:undetectable;1uw6Q-6gngA:undetectable"],["1UW6_T_NCTT1208_1","ACETYLCHOLINE-BINDING PROTEIN;ACETYLCHOLINE-BINDING PROTEIN","6gng","-","-",4,"LEU A 441;TYR A 532;TRP A 525;CYH A 436","None;None;None;QPS A 601 (-4.8A)","1.44A","1uw6P-6gngA:undetectable;1uw6T-6gngA:undetectable","1uw6P-6gngA:undetectable;1uw6T-6gngA:undetectable"],["2ECP_A_ACRA992_1","MALTODEXTRIN PHOSPHORYLASE","6gng","-","-",5,"LEU A  38;TYR A 120;ASP A 127;ASP A 169;ARG A 356","QPS A 601 (-4.1A);QPS A 601 (-4.4A);QPS A 601 (-2.9A);QPS A 601 (-3.3A);ADP A 602 ( 3.6A)","0.99A","2ecpA-6gngA:22.5","2ecpA-6gngA:undetectable"],["2ECP_A_ACRA992_1","MALTODEXTRIN PHOSPHORYLASE","6gng","-","-",5,"LEU A  38;TYR A 120;ASP A 169;HIS A 171;ARG A 356","QPS A 601 (-4.1A);QPS A 601 (-4.4A);QPS A 601 (-3.3A);QPS A 601 (-4.2A);ADP A 602 ( 3.6A)","0.88A","2ecpA-6gngA:22.5","2ecpA-6gngA:undetectable"],["2ECP_B_ACRB992_1","MALTODEXTRIN PHOSPHORYLASE","6gng","-","-",5,"LEU A  38;TYR A 120;ASP A 127;ASP A 169;ARG A 356","QPS A 601 (-4.1A);QPS A 601 (-4.4A);QPS A 601 (-2.9A);QPS A 601 (-3.3A);ADP A 602 ( 3.6A)","0.94A","2ecpB-6gngA:22.5","2ecpB-6gngA:undetectable"],["2ECP_B_ACRB992_1","MALTODEXTRIN PHOSPHORYLASE","6gng","-","-",5,"LEU A  38;TYR A 120;ASP A 169;HIS A 171;ARG A 356","QPS A 601 (-4.1A);QPS A 601 (-4.4A);QPS A 601 (-3.3A);QPS A 601 (-4.2A);ADP A 602 ( 3.6A)","0.87A","2ecpB-6gngA:22.5","2ecpB-6gngA:undetectable"],["2G78_A_REAA200_1","CELLULAR RETINOIC ACID-BINDING PROTEIN 2","6gng","-","-",5,"ALA A 141;THR A  72;VAL A  87;LEU A 151;MET A  57","None","1.13A","2g78A-6gngA:undetectable","2g78A-6gngA:undetectable"],["2OKC_A_SAMA500_0","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","6gng","-","-",5,"GLY A 121;GLY A 125;THR A 115;SER A  27;PHE A 135","None;QPS A 601 (-3.4A);None;None;None","1.06A","2okcA-6gngA:undetectable","2okcA-6gngA:undetectable"],["2YLD_A_ASCA130_0","CYTOCHROME C'","6gng","-","-",4,"ALA A 369;GLY A 498;CYH A 499;LYS A 500","None","1.25A","2yldA-6gngA:undetectable","2yldA-6gngA:undetectable"],["2YLG_A_ASCA130_0","CYTOCHROME C'","6gng","-","-",4,"ALA A 369;GLY A 498;CYH A 499;LYS A 500","None","1.43A","2ylgA-6gngA:undetectable","2ylgA-6gngA:undetectable"],["3D91_A_REMA350_2","RENIN","6gng","-","-",4,"TYR A 384;ALA A 406;ALA A 424;TYR A 426","None","1.29A","3d91A-6gngA:undetectable","3d91A-6gngA:undetectable"],["3HS6_B_EPAB1_1","PROSTAGLANDIN G\/H SYNTHASE 2","6gng","-","-",5,"PHE A 470;GLY A 498;ILE A 494;GLY A 362;ALA A 363","None","0.98A","3hs6B-6gngA:undetectable","3hs6B-6gngA:undetectable"],["3KVV_E_URFE254_1","URIDINE PHOSPHORYLASE","6gng","-","-",4,"GLY A 284;GLN A 204;ILE A 291;VAL A 277","None","1.10A","3kvvE-6gngA:undetectable","3kvvE-6gngA:undetectable"],["3Q5S_A_ACHA1289_0","MULTIDRUG-EFFLUX TRANSPORTER 1 REGULATOR","6gng","-","-",4,"ASN A 216;TYR A 183;GLU A 144;ILE A  78","None","1.16A","3q5sA-6gngA:undetectable","3q5sA-6gngA:undetectable"],["3ZWI_A_ASCA156_0","CYTOCHROME C'","6gng","-","-",4,"ALA A 369;GLY A 498;CYH A 499;LYS A 500","None","1.28A","3zwiA-6gngA:undetectable","3zwiA-6gngA:undetectable"],["4ACA_C_DXCC1478_0","TRANSLATION ELONGATION FACTOR SELB","6gng","-","-",4,"GLY A 298;ILE A 299;THR A 539;PHE A 536","None","0.87A","4acaC-6gngA:6.1","4acaC-6gngA:undetectable"],["4E1V_B_URFB1301_1","URIDINE PHOSPHORYLASE","6gng","-","-",4,"GLY A 284;GLN A 204;ILE A 291;VAL A 277","None","1.07A","4e1vB-6gngA:undetectable","4e1vB-6gngA:undetectable"],["4E1V_F_URFF1301_1","URIDINE PHOSPHORYLASE","6gng","-","-",4,"GLY A 284;GLN A 204;ILE A 291;VAL A 277","None","1.11A","4e1vF-6gngA:undetectable","4e1vF-6gngA:undetectable"],["4W5O_A_IPHA904_0","PROTEIN ARGONAUTE-2","6gng","-","-",4,"ILE A 483;GLN A 242;PRO A 243;ILE A 245","None","1.07A","4w5oA-6gngA:2.2","4w5oA-6gngA:undetectable"],["4Z4E_A_IPHA904_0","PROTEIN ARGONAUTE-2","6gng","-","-",4,"ILE A 483;GLN A 242;PRO A 243;ILE A 245","None","1.08A","4z4eA-6gngA:4.2","4z4eA-6gngA:undetectable"],["4Z4G_A_IPHA902_0","PROTEIN ARGONAUTE-2","6gng","-","-",4,"ILE A 483;GLN A 242;PRO A 243;ILE A 245","None","1.07A","4z4gA-6gngA:2.5","4z4gA-6gngA:undetectable"],["5DZK_O_BEZO801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","6gng","-","-",4,"SER A  27;HIS A 171;MET A 138;LEU A 119","None;QPS A 601 (-4.2A);None;None","1.10A","5dzka-6gngA:undetectable;5dzko-6gngA:undetectable","5dzka-6gngA:undetectable;5dzko-6gngA:undetectable"],["5DZK_P_BEZP801_1","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","6gng","-","-",4,"SER A  27;HIS A 171;MET A 138;LEU A 119","None;QPS A 601 (-4.2A);None;None","1.27A","5dzkB-6gngA:3.2;5dzkP-6gngA:undetectable","5dzkB-6gngA:undetectable;5dzkP-6gngA:undetectable"],["5ESG_A_1YNA701_1","LANOSTEROL 14-ALPHA DEMETHYLASE","6gng","-","-",5,"GLU A 434;VAL A 452;GLY A 408;THR A 410;LEU A 357","QPS A 601 ( 3.7A);None;None;None;None","1.10A","5esgA-6gngA:undetectable","5esgA-6gngA:undetectable"],["5JLI_A_ASCA202_0","CYTOCHROME C'","6gng","-","-",4,"ALA A 369;GLY A 498;CYH A 499;LYS A 500","None","1.36A","5jliA-6gngA:undetectable","5jliA-6gngA:undetectable"],["5JT4_A_ASCA202_0","CYTOCHROME C'","6gng","-","-",4,"ALA A 369;GLY A 498;CYH A 499;LYS A 500","None","1.33A","5jt4A-6gngA:undetectable","5jt4A-6gngA:undetectable"],["5JW1_B_CELB602_2","PROSTAGLANDIN G\/H SYNTHASE 2","6gng","-","-",4,"VAL A 529;VAL A 166;ARG A  99;ILE A  59","None","1.08A","5jw1B-6gngA:0.0","5jw1B-6gngA:undetectable"],["5TUI_B_CTCB405_0","TETRACYCLINE DESTRUCTASE TET(50)","6gng","-","-",5,"GLY A 355;PHE A 353;VAL A 462;GLY A 457;PRO A 450","ADP A 602 ( 4.1A);None;None;None;None","1.04A","5tuiB-6gngA:undetectable","5tuiB-6gngA:undetectable"],["5VNC_C_GCSC801_1","GLYCOGEN [STARCH] SYNTHASE ISOFORM 2","6gng","-","-",5,"ARG A 356;ASN A 301;LYS A 361;GLU A 434;GLY A 437","ADP A 602 ( 3.6A);QPS A 601 (-3.2A);ADP A 602 (-2.8A);QPS A 601 ( 3.7A);ADP A 602 ( 3.6A)","1.36A","5vncC-6gngA:21.8","5vncC-6gngA:undetectable"],["5VNC_C_GCSC801_1","GLYCOGEN [STARCH] SYNTHASE ISOFORM 2","6gng","-","-",8,"GLY A  37;HIS A 199;VAL A 269;ASN A 301;LYS A 361;GLU A 434;PRO A 435;GLY A 437","ADP A 602 ( 3.4A);QPS A 601 (-4.4A);QPS A 601 ( 4.7A);QPS A 601 (-3.2A);ADP A 602 (-2.8A);QPS A 601 ( 3.7A);QPS A 601 (-3.9A);ADP A 602 ( 3.6A)","0.72A","5vncC-6gngA:21.8","5vncC-6gngA:undetectable"],["5XIQ_D_HFGD1002_1","PROLYL-TRNA SYNTHETASE (PRORS)","6gng","-","-",3,"THR A  35;GLU A  28;HIS A 171","QPS A 601 ( 3.0A);QPS A 601 ( 4.1A);QPS A 601 (-4.2A)","0.91A","5xiqD-6gngA:3.4","5xiqD-6gngA:undetectable"],["6GNE_A_ACRA602_1","-","6gng","-","-",11,"GLY A  36;GLY A  37;VAL A  41;ASP A 169;VAL A 269;ASN A 301;ARG A 356;GLN A 360;PRO A 435;CYH A 436;GLY A 437","ADP A 602 ( 3.5A);ADP A 602 ( 3.4A);None;QPS A 601 (-3.3A);QPS A 601 ( 4.7A);QPS A 601 (-3.2A);ADP A 602 ( 3.6A);QPS A 601 (-3.2A);QPS A 601 (-3.9A);QPS A 601 (-4.8A);ADP A 602 ( 3.6A)","0.48A","6gneA-6gngA:42.2","6gneA-6gngA:undetectable"],["6GNE_A_ACRA602_2","-","6gng","-","-",6,"TYR A 120;TRP A 170;HIS A 199;ASN A 200;TYR A 203;GLU A 434","QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-3.9A);QPS A 601 ( 3.7A)","0.57A","6gneA-6gngA:42.2","6gneA-6gngA:undetectable"],["6GNE_B_ACRB602_1","-","6gng","-","-",11,"GLU A  28;GLY A  36;GLY A  37;VAL A  41;ASP A 169;VAL A 269;ASN A 301;ARG A 356;GLN A 360;PRO A 435;GLY A 437","QPS A 601 ( 4.1A);ADP A 602 ( 3.5A);ADP A 602 ( 3.4A);None;QPS A 601 (-3.3A);QPS A 601 ( 4.7A);QPS A 601 (-3.2A);ADP A 602 ( 3.6A);QPS A 601 (-3.2A);QPS A 601 (-3.9A);ADP A 602 ( 3.6A)","0.49A","6gneB-6gngA:41.9","6gneB-6gngA:undetectable"],["6GNE_B_ACRB602_2","-","6gng","-","-",7,"TYR A 120;TRP A 170;HIS A 199;ASN A 200;TYR A 203;GLU A 434;CYH A 436","QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-3.9A);QPS A 601 ( 3.7A);QPS A 601 (-4.8A)","0.60A","6gneB-6gngA:41.9","6gneB-6gngA:undetectable"],["6GNF_A_QPSA602_1","-","6gng","-","-",11,"VAL A  41;ASP A 127;ASP A 169;HIS A 171;ASN A 200;ASN A 301;ARG A 356;GLN A 360;GLU A 434;PRO A 435;GLY A 437","None;QPS A 601 (-2.9A);QPS A 601 (-3.3A);QPS A 601 (-4.2A);QPS A 601 (-4.2A);QPS A 601 (-3.2A);ADP A 602 ( 3.6A);QPS A 601 (-3.2A);QPS A 601 ( 3.7A);QPS A 601 (-3.9A);ADP A 602 ( 3.6A)","0.39A","6gnfA-6gngA:54.4","6gnfA-6gngA:undetectable"],["6GNF_A_QPSA602_2","-","6gng","-","-",8,"THR A  35;GLY A  36;GLY A  37;TYR A 120;TRP A 170;HIS A 199;VAL A 269;CYH A 436","QPS A 601 ( 3.0A);ADP A 602 ( 3.5A);ADP A 602 ( 3.4A);QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-4.4A);QPS A 601 ( 4.7A);QPS A 601 (-4.8A)","0.28A","6gnfA-6gngA:54.4","6gnfA-6gngA:undetectable"],["6GNF_C_QPSC602_1","-","6gng","-","-",8,"THR A  35;GLY A  37;LEU A  38;TYR A 120;TRP A 170;HIS A 199;VAL A 269;CYH A 436","QPS A 601 ( 3.0A);ADP A 602 ( 3.4A);QPS A 601 (-4.1A);QPS A 601 (-4.4A);QPS A 601 (-4.2A);QPS A 601 (-4.4A);QPS A 601 ( 4.7A);QPS A 601 (-4.8A)","0.33A","6gnfC-6gngA:52.3","6gnfC-6gngA:undetectable"],["6GNF_C_QPSC602_2","-","6gng","-","-",11,"VAL A  41;ASP A 127;ASP A 169;HIS A 171;ASN A 200;ASN A 301;ARG A 356;GLN A 360;GLU A 434;PRO A 435;GLY A 437","None;QPS A 601 (-2.9A);QPS A 601 (-3.3A);QPS A 601 (-4.2A);QPS A 601 (-4.2A);QPS A 601 (-3.2A);ADP A 602 ( 3.6A);QPS A 601 (-3.2A);QPS A 601 ( 3.7A);QPS A 601 (-3.9A);ADP A 602 ( 3.6A)","0.41A","6gnfC-6gngA:52.3","6gnfC-6gngA:undetectable"]]